Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegoprazan vs Esomeprazole Sequential Therapy for H. pylori Eradication
NCT06382493Recruiting
- Sponsor
- Seoul National University Bundang Hospital
- Start
- Feb 2021
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of tegoprazan in Helicobacter pylori infection (2 arms), sponsored by Seoul National University Bundang Hospital. Primary endpoint: Eradication rate at 3 months. Started Feb 2021; status: recruiting.
02
Drugs
tegoprazan
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT06382493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06382493.